iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
3 hedge funds and large institutions have $2.74M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more funds holding
Funds holding: 2 → 3 (+1)
14% less capital invested
Capital invested by funds: $3.18M → $2.74M (-$438K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$76.5K |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
+$64.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$892K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $2.6M | -$892K | -35,000 | -26% |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $78K | +$76.5K | +3,000 | New |
|
|
AG
3
Advisor Group
Phoenix,
Arizona
| $65K | +$64.1K | +2,514 | New |
|
IEIH Hedge Fund Activity: Q1 2019 in Review
3 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q1 2019, worth a combined $2.74M — down 14% from $3.18M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IEIH positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $76.5K. The largest seller was BlackRock, cutting an estimated $892K.
- 3 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q1 2019, up from 2 in Q4 2018.
- Funds reported $2.74M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q1 2019, down 14% quarter-over-quarter.
- 2 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q1 2019 and 1 closed out, a net change of +1 holder.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q1 2019 was Royal Bank of Canada, an estimated $76.5K added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q1 2019 was BlackRock, an estimated $892K sold.
Based on aggregated 13F filings for Q1 2019.